MOMartha A. O’bRien

Martha A. O’bRien

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Martha A. O’bRien has a total of 66 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Interrogating direct NLRP3 engagement and functional inflammasome inhibition using cellular assays

    by Kelly A. Teske, Cesear Corona, Jennifer Wilkinson, Daniel Mamott, David A. Good, Delia Zambrano, Dan F. Lazar, James J. Cali, Matthew B. Robers, Martha A. O’bRien


  • Open Access

    A bioluminescent caspase-1 activity assay rapidly monitors inflammasome activation in cells

    by Martha O'BRien, Danielle Moehring, Raúl Muñoz-Planillo, Gabriel Núñez, Justin Callaway, Jenny Ting, Mike Scurria, Tim Ugo, Laurent Bernad, James Cali, et al.


  • Open Access

    EP-1387: Time Trends In Opioid Use In Cancer Patients with Pain: Observations from Administrative Data

    by L. Barbera, C. DeAngelis, C. Earle, C. Atzema, D. Dudgeon, D. Howell, A. Husain, M.A. O'Brien, H. Seow, J. Sussman, et al.

  • Homogeneous, Bioluminescent Proteasome Assays

    by Martha A. O’bRien, Richard A. Moravec, Terry L. Riss, Robert F. Bulleit

    Protein degradation is mediated predominantly through the ubiquitin–proteasome pathway. The importance of the proteasome in regulating degradation of proteins involved in cell-cycle control, apoptosis, and angiogenesis led to the recognition of the proteasome as a therapeutic target for cancer [1–6]. The proteasome is also essential for degrading misfolded and aberrant proteins, and impaired proteasome function has been implicated in neurodegerative and cardiovascular diseases [7, 8]. Robust, sensitive assays are essential for monitoring proteasome activity and for developing inhibitors of the proteasome. Peptide-conjugated fluorophores are widely used as substrates for monitoring proteasome activity, but fluorogenic substrates can exhibit significant background and can be problematic for screening because of cellular autofluorescence or interference from fluorescent library compounds. Furthermore, fluorescent proteasome assays require column-purified 20S or 26S proteasome (typically obtained from erythrocytes), or proteasome extracts from whole cells, as their samples. To provide assays more amenable to high-throughput screening, we developed a homogeneous, bioluminescent method that combines peptide-conjugated aminoluciferin substrates and a stabilized luciferase. Using substrates for the chymotrypsin-like, trypsin-like, and caspase-like proteasome activities in combination with a selective membrane permeabilization step, we developed single-step, cell-based assays to measure each of the proteasome catalytic activities. The homogeneous method eliminates the need to prepare individual cell extracts as samples and has adequate sensitivity for 96- and 384-well plates. The simple “add and read” format enables sensitive and rapid proteasome assays ideal for inhibitor screening.


  • Identifying age differences in technology usage

    by M.A. O'Brien, K.E. Olson, N. Charness, S.J. Czaja, A.D. Fisk, W.A. Rogers, J. Sharit

  • What are the supportive care service needs of recently diagnosed cancer patients? Results of a population based study

    by J. Sussman, T. Whelan, E. Grunfeld, A. Willan, S. Sellick, M. A. O’brien, S. Schiff, A. Edwardson

    8096 Background: Previous studies have suggested that a substantial proportion of recently diagnosed cancer patients may have unmet supportive care needs. As part of a cancer supportive care initiative in the province of Ontario Canada, we evaluated patients’ need, use and access to supportive care services. Methods: A prospective cross-sectional population based survey of patients with breast, colorectal and prostate cancers randomly selected from a provincial registry who were within 12 months of diagnosis was performed in 3 representative regions of the province of Ontario, Canada between June 2001 and April 2003. A validated, self- completed supportive care questionnaire that reviewed 46 unique core supportive care services was mailed to patients. Respondents indicated whether a particular service type was needed and used during the previous 12 months. Need and use scores were tabulated by adding the number of services chosen (score range 0–46). Access was measured by the gap between need and use of services. Demographic variables were collected to study predictive factors for need and use. Results: Responses were obtained from 2733 patients representing an adjusted response rate of 76%. Mean respondent age was 65.9 years with 51% of respondents being female. 83.5% attended a cancer centre in the previous 12 months. Mean need score from all respondents was 10.8 (SD 6.9). Need scores appeared highest for Information, Psychological and Physical Services. On multivariate regression, a higher need was predicted by: lower age, gender (female), non-attendance at a cancer centre, lower socioeconomic status, and disease type (breast) (all P<.001). Mean use score for all respondents was 8.7 (SD 5.1). In fewer than 10% of respondents a gap between need and use was recorded. Conclusions: Cancer patients reported need and use of few specific supportive care services in this population based survey. In contrast to previous studies, access did not appear to be a significant problem based on a small gap between need and use of services. Patient reported needs varied by a number of demographic factors. These findings are important for the planning of supportive care services in cancer centres and communities. No significant financial relationships to disclose.

  • Open Access

    Homogeneous, Bioluminescent Protease Assays: Caspase-3 as a Model

    by Martha A. O’bRien, William J. Daily, P. Eric Hesselberth, Richard A. Moravec, Michael A. Scurria, Dieter H. Klaubert, Robert F. Bulleit, Keith V. Wood


    • 1 August 2001
      • Vol. 39  (8)
    Top Cited Papers

    Changing provider behavior: an overview of systematic reviews of interventions.

    by J M Grimshaw, L Shirran, R Thomas, G Mowatt, C Fraser, L Bero, Roberto Grilli, E Harvey, A Oxman, M A O'brien

    Background: Increasing recognition of the failure to translate research findings into practice has led to greater awareness of the importance of using active dissemination and implementation strategies. Although there is a growing body of research evidence about the effectiveness of different strategies, this is not easily accessible to policy makers and professionals. Objectives: To identify, appraise, and synthesize systematic reviews of professional educational or quality assurance interventions to improve quality of care. Research design: An overview was made of systematic reviews of professional behavior change interventions published between 1966 and 1998. Results: Forty-one reviews were identified covering a wide range of interventions and behaviors. In general, passive approaches are generally ineffective and unlikely to result in behavior change. Most other interventions are effective under some circumstances; none are effective under all circumstances. Promising approaches include educational outreach (for prescribing) and reminders. Multifaceted interventions targeting different barriers to change are more likely to be effective than single interventions. Conclusions: Although the current evidence base is incomplete, it provides valuable insights into the likely effectiveness of different interventions. Future quality improvement or educational activities should be informed by the findings of systematic reviews of professional behavior change interventions.


  • Nursing interventions to decrease bleeding at the femoral access site after percutaneous coronary intervention. SANDBAG Nursing Coordinators. Standards of Angioplasty Nursing Techniques to Diminish Bleeding Around the Groin

    by Nb Juran, Cl Rouse, Dd Smith, Ma O'Brien, SA DeLuca, K Sigmon

    BACKGROUND: This trial is the first prospective, multicenter clinical nursing trial conducted to measure the effect of nursing interventions on bleeding at the femoral access site after percutaneous coronary intervention with or without a potent antiplatelet agent given along with heparin and aspirin. OBJECTIVE: To measure the relationship between nursing interventions and complications at the arterial access site in patients undergoing percutaneous coronary interventions and to recommend a standard of care to minimize bleeding complications. METHODS: In a descriptive, correlational 4010-patient study, nursing care interventions after coronary procedures were measured. Observed standards of care were assessed, and regression techniques were used to evaluate nursing interventions and the effect of the interventions on bleeding at the access site after percutaneous coronary procedures. RESULTS: Several significant correlations between nursing interventions and the occurrences of moderate to severe bleeding at the access site were found; however, most interventions had little effect. The most significant factors in decreasing complications at the access site were early removal of the arterial sheath, the type of pressure mechanism used to achieve arterial hemostasis, staffing allocation, and the person and method used to remove the sheath. CONCLUSION: Many nursing interventions after percutaneous coronary intervention have become routine in the absence of clinical outcome data. Most nursing interventions aimed at decreasing bleeding at the vascular access site increase nursing workload but do not significantly affect bleeding in the groin. These results underscore the importance of continued clinical research studies to validate nursing practice on the basis of patients' outcomes.


    • 1 March 1992
      • Vol. 11  (3) , 246-54

    Systemic absorption of intraperitoneal antimicrobials in continuous ambulatory peritoneal dialysis.

    by M A O'Brien, N A Mason

    The factors that influence drug movement across the peritoneum are presented, and the feasibility of administering antimicrobials intraperitoneally to treat systemic infections in patients undergoing continuous ambulatory peritoneal dialysis (CAPD) is explored. Antimicrobials are often administered intraperitoneally to treat peritonitis in patients undergoing CAPD. It would be advantageous to administer antimicrobials by the same route to treat systemic infections as well. Factors that determine the propensity of a drug to cross the peritoneal membrane include molecular weight, protein binding, volume of distribution, ionic charge, water or lipid solubility, the permeability and surface area of the peritoneum, blood flow rate, dialysate dwell time, and the concentration of dextrose in the dialysate. The bioavailability of i.p. drugs has been determined (1) by measuring the area under the plasma concentration-time curve (AUC) of an i.p. dose and comparing it with the AUC of the same dose given i.v. and (2) by estimating the residual drug content in the dialysate after a specified dwell period. Pharmacokinetic studies show that the bioavailabilities of antimicrobials given intraperitoneally in patients undergoing CAPD range from 50% to 92%. Vancomycin has been the agent most widely studied. Serum antimicrobial concentrations achieved by this route of administration are in many cases similar to those accomplished by the i.v. route and within the therapeutic range. Dosage regimens based on the pharmacokinetic data have been suggested; however, their efficacy has not been formally documented. The intraperitoneal route may have a role in the treatment of systemic infections in peritoneal dialysis patients, but specific recommendations cannot be made until clinical studies have been performed.